AN Insight Into Inflammatory Bowel Disease
INFLAMATORY bowel disease (IBD) is a complicated chronic condition characterised by relapsing and remitting inflammation of the gastrointestinal tract. The main forms of the condition are crohn’s disease and ulcerative colitis. Those with inflammatory bowel disease may experience nausea, vomiting, abdominal pain, diarrhoea, muscle spasms amongst others. It may arise due to a combination of genetic and environmental factors which cause inflammation of the intestine. The infiltration of the intestinal wall by microbiota is thought to play a vital role in the development of IBD; this may trigger exaggerated immunological responses that damages the intestinal lining further. Dietary choices are also believed to play a part in causing and worsening IBD. The input of genetics in the development of IBD is still not well understood. IBD may be diagnosed by excluding other possible triggers of its typical features.
Pharmacotherapy may be used to manage symptoms of IBD. This typically involves the use of aminosalicyclates such as mesalazine. Effective dietary measures may include restricting intake of fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAPS). Low fibre diets may also be beneficial. As iron deficiency is often a feature of IBD, supplementary intake of iron maybe required.
IBD can be a highly self-limiting condition, however, Sufficient medical and psychological intervention can help those with IBS live a good quality life.